How long does patent approval take for capital in China?

Patent approval timelines in China vary dramatically by type: invention patents (发明专利, fāmíng zhuānlì) take 18–36 months from filing to grant, while utility models (实用新型, shíyòng xīnxíng) and design patents (外观设计, wàiguān shèjì) typically issue in 6–12 months each. For foreign-invested and capital-intensive companies building IP portfolios in China, these timelines directly affect valuation, licensing strategies, and competitive moats. The 2020 amendment to the Patent Law of the People’s Republic of China (effective June 1, 2021) introduced significant changes — including patent term compensation and good-faith filing requirements — that every foreign investor must understand before committing resources to Chinese patent prosecution. This FAQ breaks down the approval process, timelines, acceleration options, and compliance obligations for foreign applicants.

What Are the Standard Patent Approval Timelines in China?

China’s patent system grants three types of patents under the Patent Law, each with a distinct examination pathway and timeline. The China National Intellectual Property Administration (CNIPA, 国家知识产权局, guójiā zhīshì chǎnquán jú) handles all patent filings and examinations.

Invention patents undergo substantive examination — the longest and most rigorous process. Utility models and design patents receive only preliminary examination (formal requirements and basic novelty check), which accounts for their faster issuance. However, the 2020 amendment introduced partial substantive examination for design patents, which may lengthen timelines incrementally for design applications filed after June 1, 2021.

According to CNIPA’s 2023 annual report, the average examination period for invention patents had been compressed to approximately 16.5 months for first office action, though total grant timelines remain in the 18–36 month range due to applicant response cycles. [Source: CNIPA Annual Report 2023, Patent Examination Statistics]

What Is the Regulatory Basis for Patent Timelines in China?

Patent approval timelines in China are governed primarily by the Patent Law of the People’s Republic of China (中华人民共和国专利法, zhōngguó rénmín gònghéguó zhuānlì fǎ) and its Implementing Regulations, alongside the Patent Examination Guidelines (专利审查指南, zhuānlì shěnchá zhǐnán) published by CNIPA.

The current legal framework rests on the 2020 amendment to the Patent Law, which took effect on June 1, 2021 — the fourth comprehensive revision since the original 1984 law. Key articles affecting timelines and foreign applicants include:

• Article 18 — Mandates that foreign individuals or enterprises without a habitual residence or business establishment in China must entrust a legally established patent agency (专利代理机构, zhuānlì dàilǐ jīgòu) to file and prosecute patent applications in China. This mandatory agency requirement adds a procedural step but does not inherently lengthen substantive examination timelines.
• Article 19 — Requires that any invention made in China by a foreign applicant or a Chinese entity subject to confidentiality review (保密审查, bǎomì shěnchá) must first be submitted to CNIPA for a confidentiality check before filing abroad. The confidentiality review period is typically 4–6 months, which can delay foreign priority filings if not planned for.
• Article 42 — Establishes the protection terms: 20 years for invention patents, 10 years for utility models, and 15 years for design patents. The 2020 amendment introduced patent term compensation (专利权期限补偿, zhuānlì quán qīxiàn bǔcháng) for invention patents, granting up to 5 years of additional term to compensate for examination delays exceeding 4 years from filing or 3 years from the examination request.
• Article 48 — Introduces the good-faith principle (诚实信用原则, chéngshí xìnyòng yuánzé), requiring all patent filings to be made in good faith. Abuse of the patent application process can result in rejection or invalidation, which may de facto extend timelines through reexamination or litigation.

[Source: Patent Law of the People’s Republic of China (2020 Amendment), Articles 18, 19, 42, 48]

What Is the Step-by-Step Patent Examination Process in China?

The journey from filing to grant follows a structured sequence of procedural steps. Below is the complete ordered process for an invention patent — the longest pathway — with differences noted for utility model and design patents.

1. Filing and Formal Examination (受理和初步审查, shòulǐ hé chūbù shěnchá) — The applicant submits the application (including specification, claims, abstract, and drawings where applicable) in Chinese, either directly to CNIPA or through a registered patent agency. Formal examination checks compliance with basic requirements: completeness of documents, clarity of drawings, and payment of filing fees. This stage typically takes 2–4 months. For foreign applicants, Article 18 compliance (agency appointment) is verified at this stage.
2. Confidentiality Review (if applicable) (保密审查, bǎomì shěnchá) — If the invention was made in China and the applicant intends to file abroad, Article 19 requires a prior confidentiality review by CNIPA. This review takes approximately 4–6 months and must be completed before any foreign filing. Foreign applicants filing directly in China based on a foreign priority application are generally exempt, but the rule applies to inventions actually created in China.
3. Publication (公布, gōngbù) — For invention patents, the application is automatically published 18 months from the filing date (or priority date if a priority claim is made). Publication makes the application publicly available and establishes provisional protection under Article 13 of the Patent Law. Utility model and design patents are published upon grant, not before.
4. Substantive Examination Request (实质审查请求, shízhì shěnchá qǐngqiú) — For invention patents only, the applicant must file a request for substantive examination within 36 months of the filing date (or priority date). Failure to do so results in the application being deemed withdrawn. This request triggers the substantive examination process. Most strategic filers request examination concurrently with filing or shortly after publication to avoid delays.
5. Substantive Examination (实质审查, shízhì shěnchá) — A CNIPA examiner reviews the application for novelty (新颖性, xīnyǐngxìng), inventiveness (创造性, chuàngzàoxìng), and industrial applicability (实用性, shíyòngxìng) against prior art. The examiner issues one or more office actions (审查意见通知书, shěnchá yìjiàn tōngzhīshū). The applicant must respond within 4 months of each office action, extendable by up to 2 months upon request. The examination timeline is heavily influenced by the number of office actions and the speed of applicant responses.
6. Grant and Registration (授权和登记, shòuquán hé dēngjì) — Once the examiner determines the application meets all requirements, a grant notification is issued. The applicant must pay the registration fee and annual fee within 2 months of the notification. Upon payment, the patent is registered, published in the CNIPA Patent Gazette (专利公报, zhuānlì gōngbào), and a patent certificate is issued. The total elapsed time from grant notification to certificate issuance is typically 1–2 months.
7. Annual Fee Maintenance (年费缴纳, niánfèi jiǎonà) — After grant, annual fees must be paid each year before the anniversary of the filing date to maintain the patent in force. Late payment is permitted within a 6-month grace period with a surcharge. Non-payment results in patent lapse.

For utility model and design patents, steps 3 (publication) and 4 (substantive examination request) are skipped entirely — these patents proceed directly from formal examination to grant. The entire utility model process typically completes in 6–12 months, and design patents in 6–12 months as well.

How Can Foreign Investors Accelerate Patent Approval in China?

For capital-intensive companies where time-to-grant directly impacts investment rounds, licensing deals, or litigation readiness, several acceleration mechanisms are available under Chinese law.

• Patent Prosecution Highway (PPH, 专利审查高速路, zhuānlì shěnchá gāosù lù) — CNIPA has bilateral PPH agreements with patent offices in over 30 countries including the USPTO, EPO, JPO, and KIPO. Under PPH, an applicant whose claims have been found allowable in one participating office can request accelerated examination in CNIPA for corresponding claims. PPH applications typically receive first office action within 3–6 months, compared to the standard 12–18 months. For foreign investors with parallel filings in the US or Europe, PPH is the most cost-effective acceleration strategy. [Source: CNIPA PPH Program Guide, 2024 Edition]
• Priority Examination (优先审查, yōuxiān shěnchá) — Under the Priority Examination Program (Patent Priority Examination Management Measures, 2017), applicants can request accelerated examination for invention patents in specific technology fields: energy conservation, environmental protection,新一代信息技术 (next-generation information technology), biology, high-end equipment manufacturing, and others. Priority examination targets a completion timeline of 12 months for invention patents and 2 months for utility model and design patents. However, it requires the application to have been published and for the applicant to submit a prior art search report. Foreign applicants can use this program equally with Chinese entities.
• Patent Term Compensation (专利权期限补偿, zhuānlì quán qīxiàn bǔcháng) — Post-Grant — Introduced in the 2020 amendment, Article 42(2) allows invention patentees to apply for term compensation if the total examination period exceeds 4 years from filing or 3 years from the examination request. The compensation period equals the delay beyond those thresholds, capped at 5 years. This does not accelerate the examination itself, but it mitigates the economic impact of unusually long examination by extending the monopoly period after grant. For capital firms looking at exit timelines, this can preserve patent value that would otherwise erode during protracted prosecution.
• Third-Party Observations (第三方意见, dì-sānfāng yìjiàn) — While not an acceleration mechanism per se, third-party observations allow competitors or interested parties to submit prior art to CNIPA during the examination process. For foreign investors conducting due diligence, monitoring third-party observations can provide early intelligence on potential invalidity risks, allowing strategic decisions about whether to maintain prosecution or abandon an application before significant costs accumulate.
• Direct Filing Strategy Considerations — Filing directly in China without claiming Paris Convention priority (a “first filing” strategy) can save the 12-month priority year, reducing the total elapsed time by approximately 12 months compared to a priority claim. However, this strategy carries risk if the invention is not fully developed at the time of Chinese filing, as no later foreign priority can be added. For capital firms with early-stage portfolio companies entering China, this trade-off should be evaluated on a case-by-case basis.

It is important to note that acceleration mechanisms require proactive management. A foreign investor’s patent agency must specifically request PPH or priority examination — these are not automatic. Additionally, acceleration often requires narrower claim scope, so the decision to accelerate should balance speed against the breadth of protection obtained. For many capital-intensive companies, the optimal strategy involves filing a broad initial application with standard examination while simultaneously filing narrower divisional applications under PPH for claims that are commercially critical and time-sensitive.

What Special Requirements Apply to Foreign Patent Applicants in China?

Foreign individuals and entities face specific legal requirements under the Patent Law that can affect both timelines and strategy. Understanding these requirements upfront — before filing — is essential for avoiding procedural delays and rejection risks.

Mandatory Agency Representation (Article 18)

Article 18 of the Patent Law states: “Where any foreign person, foreign enterprise, or other foreign organization having no habitual residence or business establishment in China applies for a patent or has other patent matters in China, the application and other matters shall be handled by a patent agency lawfully established in China.” This means every foreign applicant without a physical presence in China must appoint a registered Chinese patent agency (专利代理机构, zhuānlì dàilǐ jīgòu) to act as their representative before CNIPA. The agency handles all filings, responses to office actions, fee payments, and correspondence with CNIPA.

The mandatory agency requirement adds approximately 1–2 weeks to the initial filing timeline for document preparation and power-of-attorney notarization. However, it does not substantively affect examination timelines — the agency’s role is procedural, and CNIPA examines all applications on the same legal standard regardless of whether the applicant is domestic or foreign. What foreign investors should budget for is the agency cost: reputable Chinese patent agencies typically charge USD 3,000–8,000 for invention patent prosecution (filing through grant), depending on complexity and technology field.

Confidentiality Review Requirement (Article 19)

Article 19 imposes a critical timing constraint: “Where any invention made in China is to be filed for a patent abroad, it must be submitted to the patent administration department under the State Council for confidentiality review.” The key phrase is “made in China” — this applies to any invention created by a foreign entity’s R&D personnel physically working in China, even if the foreign entity itself is headquartered abroad.

The confidentiality review process works as follows: the applicant files a Chinese patent application first, and CNIPA determines within 4–6 months whether the invention involves national security or major national interests. Only after receiving CNIPA’s clearance can the applicant file corresponding applications abroad. If the foreign applicant files abroad first without this review, the Chinese application (and any Chinese patent ultimately granted) may be invalidated.

For capital firms funding portfolio companies with R&D operations in China, this means a mandatory 4–6 month delay before any foreign filing for China-originated inventions. Strategic planning should account for this by filing Chinese applications well in advance of any anticipated foreign filing deadlines, or by ensuring that key inventions are structured as foreign-originated (with R&D conducted outside China) where patent strategy demands it.

Language Requirements

All patent applications in China must be filed in Chinese. While priority documents from foreign filings can be submitted in English (with a Chinese translation to follow), the initial application itself must be in Chinese. This adds a translation step of approximately 2–4 weeks for the patent agency. Machine translations are not accepted; only certified human translations by qualified patent translators are permitted. For complex technology fields such as biotechnology, pharmaceuticals, or semiconductor design, translation accuracy is critical — a mistranslated claim term can narrow protection or render a claim indefinite.

Good-Faith Filing Requirement (Article 48)

The 2020 amendment introduced Article 48, requiring that “any unit or individual that applies for a patent and exercises patent rights shall comply with the principle of good faith.” This clause targets patent trolling and abusive filings — such as systematically preempting trademarks or public-domain designs as utility models. For legitimate foreign investors, this provision is unlikely to affect prosecution timelines, but it imposes a documentation burden to demonstrate bona fide intent and technical substance. Applications that appear speculative or mass-filed without technical support may face additional scrutiny and office actions, extending timelines by 6–12 months.

[Source: Patent Law of the People’s Republic of China (2020 Amendment), Articles 18, 19, 48; Patent Examination Guidelines, Part I, Chapter 1]

Where to Go From Here

Based on what you just read:

• Ready to act? Read [guide: SLUG-TO-BE-FILLED]
• Still comparing? See [comparison: SLUG-TO-BE-FILLED]
• Need numbers? Try [tool: SLUG-TO-BE-FILLED]

— China Gateway 360 —
Remote China market entry support, built around execution.